AHL Partners LLP boosted its position in shares of Stryker Corporation (NYSE:SYK) by 271.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 79,929 shares of the medical technology company’s stock after buying an additional 58,389 shares during the period. AHL Partners LLP’s holdings in Stryker Corporation were worth $11,093,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Acrospire Investment Management LLC acquired a new position in shares of Stryker Corporation during the 2nd quarter worth approximately $111,000. Bollard Group LLC lifted its holdings in Stryker Corporation by 0.4% in the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after acquiring an additional 3 shares during the last quarter. Motco lifted its holdings in Stryker Corporation by 50.7% in the second quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after acquiring an additional 278 shares during the last quarter. Bruderman Asset Management LLC acquired a new position in Stryker Corporation in the second quarter valued at approximately $150,000. Finally, James Investment Research Inc. acquired a new position in Stryker Corporation in the second quarter valued at approximately $155,000. Institutional investors own 74.09% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/10/28/ahl-partners-llp-has-11-09-million-holdings-in-stryker-co-syk.html.
A number of analysts have issued reports on SYK shares. Jefferies Group LLC reaffirmed a “hold” rating and set a $132.00 price objective on shares of Stryker Corporation in a research report on Friday, June 30th. Morgan Stanley reaffirmed an “overweight” rating and set a $160.00 price objective (up previously from $155.00) on shares of Stryker Corporation in a research report on Monday, July 10th. BMO Capital Markets reaffirmed a “hold” rating and set a $140.00 price objective on shares of Stryker Corporation in a research report on Tuesday, July 11th. Zacks Investment Research raised Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 target price on the stock in a report on Monday, July 17th. Finally, Royal Bank Of Canada increased their target price on Stryker Corporation from $140.00 to $155.00 and gave the company an “outperform” rating in a report on Friday, July 28th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. Stryker Corporation presently has a consensus rating of “Hold” and a consensus target price of $150.86.
Shares of Stryker Corporation (NYSE SYK) traded up 7.34% on Friday, reaching $159.74. 3,209,927 shares of the company’s stock were exchanged. The stock’s 50-day moving average price is $144.88 and its 200-day moving average price is $141.56. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $160.62. The company has a market capitalization of $59.75 billion, a P/E ratio of 35.66 and a beta of 0.80.
Stryker Corporation (NYSE:SYK) last announced its earnings results on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.50 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.97 billion. Stryker Corporation had a net margin of 14.67% and a return on equity of 24.52%. The business’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period last year, the company posted $1.39 EPS. Analysts anticipate that Stryker Corporation will post $6.44 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a $0.425 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.06%. Stryker Corporation’s dividend payout ratio (DPR) is presently 36.32%.
In other news, insider Lonny J. Carpenter sold 5,000 shares of Stryker Corporation stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the sale, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of Stryker Corporation stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the sale, the insider now owns 8,983 shares in the company, valued at $1,313,853.58. The disclosure for this sale can be found here. 7.40% of the stock is owned by company insiders.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.